The Benefits of Genetic Testing for Patients with CDKL5 Deficiency Disorder and Other Rare Genetic Epilepsies
(BPT) - CDKL5 deficiency disorder, one of the most common genetic epilepsies, is estimated to occur in approximately 100 newborns in the U.S. per year.